{"organizations": [], "uuid": "911ab4e6cb1957fca7d51486bf0d50dd308b0213", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180328.html", "section_title": "Archive News &amp; Video for Wednesday, 28 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/shire-ma-takeda-pharma/japans-takeda-considering-approach-for-british-drugmaker-shire-idUSL8N1RA2A9", "country": "US", "domain_rank": 408, "title": "Japan's Takeda considering approach for British drugmaker Shire", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-28T17:35:00.000+03:00", "replies_count": 0, "uuid": "911ab4e6cb1957fca7d51486bf0d50dd308b0213"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/shire-ma-takeda-pharma/japans-takeda-considering-approach-for-british-drugmaker-shire-idUSL8N1RA2A9", "ord_in_thread": 0, "title": "Japan's Takeda considering approach for British drugmaker Shire", "locations": [], "entities": {"persons": [{"name": "takeda", "sentiment": "negative"}, {"name": "louise heavens", "sentiment": "none"}, {"name": "rahul", "sentiment": "none"}], "locations": [{"name": "japan", "sentiment": "none"}, {"name": "bengaluru", "sentiment": "none"}, {"name": "shire", "sentiment": "none"}, {"name": "britain", "sentiment": "none"}], "organizations": [{"name": "takeda pharmaceutical co ltd", "sentiment": "negative"}, {"name": "shire", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 28 (Reuters) - Takeda Pharmaceutical Co Ltd, Japan’s largest drugmaker by sales, said it was considering a possible offer for Britain’s Shire, sending shares in the pharmaceuticals company sharply higher.\nBy 0931 GMT shares in Shire were up 25 percent at 38.50 pounds ($54.55).\nTakeda’s consideration of such an offer is at a preliminary and exploratory stage and no approach has been made to the board of Shire, Takeda said in brief statement.\n$1 = 0.7058 pounds Reporting by Rahul B in Bengaluru, editing by Louise Heavens\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-03-28T17:35:00.000+03:00", "crawled": "2018-03-29T16:00:32.000+03:00", "highlightTitle": ""}